Published in Women's Health Weekly, September 6th, 1999
David Fishman, MD, Ovarian Cancer Detection Program at Northwestern University, directs the program that uses Atairgin's platform technology in lysophospholipids to develop an early detection marker for ovarian cancer. When ovarian cancer is detected early, in a localized state, over 90 percent of the women live longer than five years past diagnosis. However, with currently available diagnostics, approximately 70 percent of all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.